TScan Therapeutics, Inc. (TCRX) vs Vaxxinity, Inc. (VAXX)
- TScan Therapeutics, Inc. TCRX 0.23 −4.17%
- Vaxxinity, Inc. VAXX 0.00 NaN
TScan Therapeutics, Inc. and Vaxxinity, Inc. are both Biotechnology companies. TScan Therapeutics, Inc. and Vaxxinity, Inc. are of similar size ($16.2M and $15.5M). Vaxxinity, Inc. has the higher net margin (0.00% vs −1,655.4%) and the higher return on invested capital (0.00% vs −4,588.2%). Across the 15 metrics below, Vaxxinity, Inc. leads on 10 and TScan Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | TCRX | VAXX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | (1,695.15%) | 0.00% | 0.00% |
| Net margin | (1,655.35%) | 0.00% | 0.00% |
| Free cash flow margin | (1,665.18%) | 0.00% | 0.00% |
| Return on equity | (95.80%) | (150.65%) | (56.36%) |
| Return on assets | (50.09%) | (75.55%) | (48.04%) |
| Return on invested capital | (4,588.23%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack